See more : Paragon ID SA (PID.PA) Income Statement Analysis – Financial Results
Complete financial analysis of IMV Inc. (IMV.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IMV Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Yoshicon Co.,Ltd. (5280.T) Income Statement Analysis – Financial Results
- C-Rad AB (publ) (CRAD-B.ST) Income Statement Analysis – Financial Results
- Buima Group Inc. (5543.TWO) Income Statement Analysis – Financial Results
- Nanobiotix S.A. (NNBXF) Income Statement Analysis – Financial Results
- Fukuyama Transporting Co., Ltd. (9075.T) Income Statement Analysis – Financial Results
IMV Inc. (IMV.TO)
About IMV Inc.
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 2.35K | 45.17K | 60.20K | 0.00 | 96.50K | 93.47K | 0.00 | 0.00 | 0.00 | 0.00 | 76.09K | 6.89K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 2.35K | 45.17K | 60.20K | 0.00 | 96.50K | 93.47K | 0.00 | 0.00 | 0.00 | 0.00 | 76.09K | 6.89K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 23.28M | 23.08M | 20.86M | 14.53M | 9.44M | 4.70M | 2.59M | 3.29M | 3.05M | 2.39M | 3.35M | 4.15M | 3.78M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.99M | 16.02M | 11.92M | 7.76M | 6.79M | 5.11M | 2.86M | 2.83M | 2.39M | 2.53M | 2.96M | 0.00 | 3.31M | 74.91K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.51K | 0.00 | 0.00 |
| SG&A | 16.99M | 16.02M | 11.92M | 7.76M | 6.79M | 5.11M | 2.86M | 2.83M | 2.39M | 2.53M | 2.96M | 2.32M | 3.31M | 68.40K | 21.23K | 54.58K |
| Other Expenses | -1.78M | -3.23M | -5.25M | -1.86M | -779.72K | -857.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 38.49M | 35.87M | 27.54M | 20.44M | 15.44M | 8.95M | 5.45M | 6.13M | 5.44M | 4.92M | 6.31M | 6.48M | 7.21M | 68.40K | 21.23K | 54.58K |
| Cost & Expenses | 38.49M | 35.87M | 27.54M | 20.44M | 15.44M | 8.95M | 5.45M | 6.13M | 5.44M | 4.92M | 6.31M | 6.48M | 7.21M | 68.40K | 21.23K | 54.58K |
| Interest Income | 501.00K | 188.00K | 233.70K | 389.66K | 294.41K | 150.32K | 0.00 | 0.00 | 0.00 | 303.01K | 0.00 | 0.00 | 0.00 | 6.89K | 12.73K | 0.00 |
| Interest Expense | 501.00K | 907.00K | 28.23K | 948.50K | 1.02M | 768.24K | 1.12M | 289.25K | 217.01K | 322.63K | 148.39K | 190.34K | 0.00 | 0.00 | 0.00 | -54.58K |
| Depreciation & Amortization | 1.00M | 541.00K | 403.87K | 404.20K | 238.61K | 111.28K | 78.24K | 71.85K | 88.66K | 107.93K | 134.24K | 128.31K | 117.98K | 0.00 | 0.00 | 0.00 |
| EBITDA | -38.49M | -35.14M | -26.90M | -19.60M | -14.85M | -8.69M | -5.27M | -5.96M | -5.35M | -4.81M | -6.18M | -6.35M | -7.02M | -61.50K | -21.23K | -54.58K |
| EBITDA Ratio | 0.00% | 0.00% | -1,143,466.67% | -43,387.18% | -24,664.74% | 0.00% | -5,466.29% | -6,379.05% | 0.00% | 0.00% | 0.00% | 0.00% | -9,220.97% | -892.58% | 0.00% | 0.00% |
| Operating Income | -39.49M | -35.68M | -27.31M | -20.00M | -15.09M | -12.14M | -7.20M | -8.37M | -6.32M | -5.24M | -6.43M | -6.48M | -7.13M | -61.50K | -21.23K | -54.58K |
| Operating Income Ratio | 0.00% | 0.00% | -1,160,633.33% | -44,282.11% | -25,061.08% | 0.00% | -7,456.23% | -8,958.82% | 0.00% | 0.00% | 0.00% | 0.00% | -9,376.03% | -892.58% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.50M | -907.00K | 205.46K | -558.84K | -722.45K | 2.58M | 576.69K | 2.05M | 658.17K | 621.49K | -33.40K | 0.00 | 632.45K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -37.99M | -36.59M | -27.33M | -20.95M | -16.10M | -9.57M | -6.62M | -6.32M | -5.66M | -4.61M | -6.46M | 0.00 | -6.50M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | -1,161,833.33% | -46,382.15% | -26,750.11% | 0.00% | -6,858.61% | -6,765.39% | 0.00% | 0.00% | 0.00% | 0.00% | -8,544.86% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -1.00M | 907.00K | 28.23K | 948.50K | 1.02M | 0.00 | 1.12M | 2.34M | 0.00 | -217.42K | -27.14K | 190.34K | 0.00 | 61.50K | -11.98K | 54.58K |
| Net Income | -36.99M | -37.50M | -27.36M | -21.90M | -17.12M | -9.57M | -6.62M | -6.32M | -5.66M | -4.40M | -6.43M | -6.67M | -6.50M | -61.50K | -9.25K | -54.58K |
| Net Income Ratio | 0.00% | 0.00% | -1,163,033.33% | -48,482.19% | -28,439.14% | 0.00% | -6,858.61% | -6,765.39% | 0.00% | 0.00% | 0.00% | 0.00% | -8,544.86% | -892.58% | 0.00% | 0.00% |
| EPS | -4.43 | -5.05 | 0.00 | -4.41 | -3.91 | -2.47 | -2.09 | -2.20 | -2.17 | -2.05 | -3.33 | -3.95 | -4.35 | -0.82 | -0.13 | -1.13 |
| EPS Diluted | -4.43 | -5.05 | 0.00 | -4.41 | -3.91 | -2.47 | -2.09 | -2.20 | -2.17 | -2.05 | -3.33 | -3.95 | -4.35 | -0.82 | -0.13 | -1.13 |
| Weighted Avg Shares Out | 8.34M | 7.42M | 0.00 | 4.97M | 4.38M | 3.87M | 3.16M | 2.87M | 2.61M | 2.15M | 1.93M | 1.69M | 1.49M | 75.00K | 73.39K | 48.35K |
| Weighted Avg Shares Out (Dil) | 8.34M | 7.42M | 0.00 | 4.97M | 4.38M | 3.87M | 3.16M | 2.87M | 2.61M | 2.15M | 1.93M | 1.69M | 1.49M | 75.00K | 73.39K | 48.35K |
Source: https://incomestatements.info
Category: Stock Reports